Longevity Health Holdings, Inc. financial data

Symbol
XAGE, XAGEW on OTC
Location
Pittsburgh, PA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 37% % -70.97%
Quick Ratio 14% %
Debt-to-equity -172.87% % -151.91%
Return On Equity 141% %
Return On Assets -193.97% % -497.65%
Operating Margin -400.96% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,781,738 shares -91.48%
Common Stock, Shares, Outstanding 1,781,738 shares -91.48%
Entity Public Float $25,100,000 USD -84.22%
Common Stock, Value, Issued $178 USD -91.49%
Weighted Average Number of Shares Outstanding, Basic 1,723,434 shares 147%
Weighted Average Number of Shares Outstanding, Diluted 1,723,434 shares 147%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,457,308 USD 1,975%
Research and Development Expense $873,826 USD 321%
Selling and Marketing Expense $1,145,567 USD 199%
General and Administrative Expense $1,430,908 USD
Operating Income (Loss) $-5,843,249 USD -35.12%
Nonoperating Income (Expense) $9,627 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $-5,833,622 USD 40%
Income Tax Expense (Benefit) $-97,279 USD
Net Income (Loss) Attributable to Parent $-5,736,343 USD 8.9%
Earnings Per Share, Basic 8 USD/shares 80%
Earnings Per Share, Diluted 8 USD/shares 80%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,137,325 USD -85.73%
Accounts Receivable, after Allowance for Credit Loss, Current $46,522 USD
Inventory, Net $1,013,368 USD 935%
Other Assets, Current $17,563 USD
Assets, Current $2,843,947 USD 51%
Property, Plant and Equipment, Net $116,754 USD -11.02%
Operating Lease, Right-of-Use Asset $322,047 USD -20.48%
Assets $3,298,979 USD 35%
Accounts Payable, Current $4,171,099 USD -1.02%
Liabilities, Current $6,840,994 USD 11%
Operating Lease, Liability, Noncurrent $239,259 USD -28.06%
Liabilities $7,276,342 USD 12%
Retained Earnings (Accumulated Deficit) $-73,693,722 USD -8.44%
Stockholders' Equity Attributable to Parent $-3,977,363 USD 2.1%
Liabilities and Equity $3,298,979 USD 35%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-752,953 USD 30%
Net Cash Provided by (Used in) Financing Activities $1,515,861 USD
Net Cash Provided by (Used in) Investing Activities $-150,000 USD 80%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 1,781,738 shares -91.48%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,109,228 USD -2.47%
Interest Paid, Excluding Capitalized Interest, Operating Activities $4,993 USD -56.83%
Deferred Tax Assets, Valuation Allowance $16,464,189 USD 36%
Deferred Tax Assets, Gross $16,464,189 USD 36%
Operating Lease, Liability $397,835 USD -53.08%
Depreciation $15,132 USD -10.1%
Lessee, Operating Lease, Liability, to be Paid $463,104 USD -54.8%
Property, Plant and Equipment, Gross $877,403 USD
Operating Lease, Liability, Current $93,314 USD 8.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two $115,776 USD -43.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $115,776 USD -43.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $65,269 USD -63.08%
Lessee, Operating Lease, Liability, to be Paid, Year Three $115,776 USD -43.5%
Deferred Tax Assets, Operating Loss Carryforwards $8,909,827 USD 1.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $115,776 USD -43.5%
Operating Lease, Payments $34,839 USD 11%
Additional Paid in Capital $69,716,181 USD 9.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $1,136 USD -0.79%
Depreciation, Depletion and Amortization $80,851 USD -8.77%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $765,256 USD 23%
Interest Expense $20,106 USD -28.98%